Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaime Prat

Showing results (91-100 of 123) with videos related to

Pageof 13
Sort By:
Human Pathology|June 28, 2016
CD8 down-regulation on cytotoxic T lymphocytes of patients with endometrioid endometrial carcinomasMónica Pascual-García, Cristina Bértolo, Juan C Nieto, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 13, 2008
Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinomaJudit Pallarés, Ana Velasco, Nuria Eritja, et al.
Virchows Archiv : an International Journal of Pathology|June 30, 2012
Role of tumor-associated macrophages and angiogenesis in desmoid-type fibromatosisStefhanie Romero, Justyna Szafranska, Eliovel Cabrera, et al.
Oncogene|September 5, 2003
Cyclin D1 gene (CCND1) mutations in endometrial cancerGema Moreno-Bueno, Sandra Rodríguez-Perales, Carolina Sánchez-Estévez, et al.
The Journal of Pathology|March 14, 2003
Abnormalities of E- and P-cadherin and catenin (beta-, gamma-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasiaGema Moreno-Bueno, David Hardisson, David Sarrió, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 4, 2004
Immunohistochemical analysis of PTEN in endometrial carcinoma: a tissue microarray study with a comparison of four commercial antibodies in correlation with molecular abnormalitiesJudit Pallares, Elena Bussaglia, Jose Luis Martínez-Guitarte, et al.
Journal of Cutaneous Pathology|July 26, 2002
Microsatellite instability and immunostaining for MSH-2 and MLH-1 in cutaneous and internal tumors from patients with the Muir-Torre syndromePilar Machin, Lluis Catasus, Cristina Pons, et al.
Histopathology|November 7, 2017
Germ cell tumour growth patterns originating from clear cell carcinomas of the ovary and endometrium: a comparative immunohistochemical study favouring their origin from somatic stem cellsFrancisco F Nogales, Jaime Prat, Maolly Schuldt, et al.
Human Pathology|August 7, 2004
Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectivesDebra A Bell, Teri A Longacre, Jaime Prat, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 22, 2007
Immunohistochemical heterogeneity of breast carcinomas negative for estrogen receptors, progesterone receptors and Her2/neu (basal-like breast carcinomas)Enrique Lerma, Gloria Peiro, Teresa Ramón, et al.
Pageof 13

Showing results (91-100 of 123) with videos related to

Sort By:
Pageof 13
Human Pathology|June 28, 2016
CD8 down-regulation on cytotoxic T lymphocytes of patients with endometrioid endometrial carcinomasMónica Pascual-García, Cristina Bértolo, Juan C Nieto, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 13, 2008
Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinomaJudit Pallarés, Ana Velasco, Nuria Eritja, et al.
Virchows Archiv : an International Journal of Pathology|June 30, 2012
Role of tumor-associated macrophages and angiogenesis in desmoid-type fibromatosisStefhanie Romero, Justyna Szafranska, Eliovel Cabrera, et al.
Oncogene|September 5, 2003
Cyclin D1 gene (CCND1) mutations in endometrial cancerGema Moreno-Bueno, Sandra Rodríguez-Perales, Carolina Sánchez-Estévez, et al.
The Journal of Pathology|March 14, 2003
Abnormalities of E- and P-cadherin and catenin (beta-, gamma-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasiaGema Moreno-Bueno, David Hardisson, David Sarrió, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 4, 2004
Immunohistochemical analysis of PTEN in endometrial carcinoma: a tissue microarray study with a comparison of four commercial antibodies in correlation with molecular abnormalitiesJudit Pallares, Elena Bussaglia, Jose Luis Martínez-Guitarte, et al.
Journal of Cutaneous Pathology|July 26, 2002
Microsatellite instability and immunostaining for MSH-2 and MLH-1 in cutaneous and internal tumors from patients with the Muir-Torre syndromePilar Machin, Lluis Catasus, Cristina Pons, et al.
Histopathology|November 7, 2017
Germ cell tumour growth patterns originating from clear cell carcinomas of the ovary and endometrium: a comparative immunohistochemical study favouring their origin from somatic stem cellsFrancisco F Nogales, Jaime Prat, Maolly Schuldt, et al.
Human Pathology|August 7, 2004
Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectivesDebra A Bell, Teri A Longacre, Jaime Prat, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 22, 2007
Immunohistochemical heterogeneity of breast carcinomas negative for estrogen receptors, progesterone receptors and Her2/neu (basal-like breast carcinomas)Enrique Lerma, Gloria Peiro, Teresa Ramón, et al.
Pageof 13